College of Pharmacy, Department of Pharmaceutics, University of Minnesota, 308 Harvard Street SE, 9-149B Weaver-Densford Hall, Minneapolis, MN 55455, USA.
Drug Metab Dispos. 2010 May;38(5):752-60. doi: 10.1124/dmd.109.031492. Epub 2010 Feb 16.
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a lung-specific tobacco carcinogen. Metabolism is critical to its elimination given its lipophilic nature. Although NNK can be metabolized through detoxification pathways that safely eliminate it from the body, it can also be bioactivated, resulting in the formation of potentially carcinogenic DNA adducts. The isolated perfused rat lung (IPRL) system was used to determine the effect of NNK perfusate concentration (0.1 and 1.2 microM) on the formation and distribution of metabolites, the level of individual DNA adducts, and total covalent binding in the lung. Coadministration of the chemopreventive agent phenethyl isothiocyanate (PEITC; 20 microM) was also examined to determine its effect on NNK metabolism. NNK was readily metabolized in the IPRL system. In the 0.1 muM perfusions approximately 55% of metabolites formed were through detoxification pathways, whereas roughly 30% were the result of bioactivation pathways. An increase in NNK concentration increased the percentage of unmetabolized NNK and decreased the apparent metabolic clearance in the lung, but the metabolite profiles remained similar between concentrations. The addition of PEITC reduced the formation of oxidative metabolites and increased 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) formation and the percentage of unmetabolized NNK. PEITC also significantly decreased the formation of DNA adducts in the lung tissue. The level of O(2)-[4-(3-pyridyl)-4-oxobut-1-yl]thymidine (O(2)-POB-dThd) and O(6)-[4-(3-pyridyl)-4-oxobut-1-yl]-2'-deoxyguanosine (O(6)-POB-dGuo) decreased by 70 to 75%, and that of O(6)-methylguanine (O(6)-methyl-Gua) and 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine (7-POB-Gua) decreased by 40 to 45%. Pyridylhydroxybutyl-DNA adducts were not detected in any of the treatment groups. Thus, the IPRL system is useful in determining pulmonary metabolism and DNA adduct formation separate from other metabolizing organs.
4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁酮(NNK)是一种肺部特异性烟草致癌物质。鉴于其亲脂性,其代谢对于其消除至关重要。尽管 NNK 可以通过解毒途径代谢,从而安全地将其从体内清除,但它也可以被生物激活,导致潜在致癌的 DNA 加合物的形成。使用离体灌流大鼠肺(IPRL)系统来确定 NNK 灌流浓度(0.1 和 1.2 μM)对代谢物的形成和分布、个体 DNA 加合物的水平以及肺中的总共价结合的影响。还检查了化学预防剂苯乙基异硫氰酸酯(PEITC;20 μM)的共给药,以确定其对 NNK 代谢的影响。NNK 在 IPRL 系统中很容易被代谢。在 0.1 μM 灌注中,形成的代谢物约有 55%是通过解毒途径形成的,而大约 30%是生物激活途径的结果。NNK 浓度的增加增加了未代谢的 NNK 的百分比,并降低了肺中的表观代谢清除率,但浓度之间的代谢物谱仍保持相似。PEITC 的添加减少了氧化代谢物的形成,增加了 4-(甲基亚硝氨基)-1-(3-吡啶基)-1-丁醇(NNAL)的形成和未代谢的 NNK 的百分比。PEITC 还显著降低了肺组织中 DNA 加合物的形成。O(2)-[4-(3-吡啶基)-4-氧代丁基]胸腺嘧啶(O(2)-POB-dThd)和 O(6)-[4-(3-吡啶基)-4-氧代丁基]-2'-脱氧鸟苷(O(6)-POB-dGuo)的水平降低了 70%至 75%,O(6)-甲基鸟嘌呤(O(6)-甲基-Gua)和 7-[4-(3-吡啶基)-4-氧代丁基]鸟嘌呤(7-POB-Gua)的水平降低了 40%至 45%。在任何治疗组中都未检测到吡啶基羟丁基-DNA 加合物。因此,IPRL 系统可用于确定肺部代谢和 DNA 加合物形成,而与其他代谢器官分开。